The following subsections delve into the roles and effectiveness of HOMA-IR, fasting insulin, and HbA1c in evaluating insulin resistance, ultimately highlighting their importance in guiding therapeutic interventions and improving outcomes for patients at risk for metabolic complications. The gene discussed is INS; the disease is Insulin resistance.